1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis

被引:27
作者
Broussy, S [1 ]
Coppel, Y [1 ]
Nguyen, M [1 ]
Bernadou, J [1 ]
Meunier, B [1 ]
机构
[1] CNRS, Chim Coordinat Lab, UPR, F-31077 Toulouse 4, France
关键词
InhA; inhibitors; isoniazid; NAD(H) adducts; oxidation;
D O I
10.1002/chem.200204637
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Isoniazid (INH) is easily oxidized with manganese(III) pyrophosphate, a chemical model of the KatG protein involved in activation of INH inside the bacteria Mycobacterium tuberculosis. Performed in the presence of NAD(+), this oxidation generates a family of isomeric INH-NAD(H) adducts, which have been shown to be effective inhibitors of InhA, an enzyme essential in mycolic acid biosynthesis. In this work, we fully characterized by H-1 and C-13 NMR spectroscopy four main species of INH-NAD(H) adducts that coexist in solution. Two of them are open diastereoisomers consisting of the covalent attachment of the isonicotinoyl radical at position four of the nicotinamide coenzyme. The other two result from a cyclization involving the amide group from the nicotinamide and the carbonyl group from the isonicotinoyl radical to give diastereoisomeric hemiamidals. Although an INH-NAD(H) adduct with a 4S configuration has been characterized within the active site of InhA from X-ray crystallography and this bound adduct interpreted as an open form (Rozwarski et al., Science 1998, 279, 98-102), it is legitimate to raise the question about the effective active form(s), open or cyclic, of INH-NAD(H) adduct(s). Is there a single active form or are several forms able to inhibit the InhA activity with different levels of inhibitory potency?.
引用
收藏
页码:2034 / 2038
页数:5
相关论文
共 18 条
[1]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[2]  
Bartmann K., 1988, Antituberculosis Drugs
[3]   Molecular mechanisms of drug resistance in Mycobacterium tuberculosis [J].
Blanchard, JS .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :215-239
[4]   STUDIES ON THE MECHANISM OF ACTION OF ISONIAZID AND ETHIONAMIDE IN THE CHEMOTHERAPY OF TUBERCULOSIS [J].
JOHNSSON, K ;
KING, DS ;
SCHULTZ, PG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (17) :5009-5010
[5]   MECHANISTIC STUDIES OF THE OXIDATION OF ISONIAZID BY THE CATALASE PEROXIDASE FROM MYCOBACTERIUM-TUBERCULOSIS [J].
JOHNSSON, K ;
SCHULTZ, PG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (16) :7425-7426
[6]   Action mechanism of antitubercular isoniazid - Activation mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor [J].
Lei, BF ;
Wei, CJ ;
Tu, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2520-2526
[7]   Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis [J].
Nguyen, M ;
Quémard, A ;
Broussy, S ;
Bernadou, J ;
Meunier, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2137-2144
[8]  
Nguyen M, 2001, CHEMBIOCHEM, V2, P877, DOI 10.1002/1439-7633(20011203)2:12<877::AID-CBIC877>3.0.CO
[9]  
2-V
[10]   ISONIAZID INHIBITION OF MYCOLIC ACID SYNTHESIS BY CELL-EXTRACTS OF SENSITIVE AND RESISTANT STRAINS OF MYCOBACTERIUM-AURUM [J].
QUEMARD, A ;
LACAVE, C ;
LANEELLE, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1035-1039